BioSyent Announces Renewal of Normal Course Issuer Bid
BioSyent Announces Renewal of Normal Course Issuer Bid GlobeNewswire December 15, 2025 MISSISSAUGA, Ontario, Dec. 15, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company's Notice of Intention to Make a Normal Course Issuer Bid (the “NCIB”). Pursuant […]